L26/O-243 How to set up an efficient IVM program
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Ho.
Abstract (Originalsprache)
Biphasic IVM represents a paradigm shift in the evolution of IVM. By introducing a pre-maturation phase that mimics natural meiotic regulation, biphasic IVM overcomes the limitations of spontaneous maturation in conventional IVM. Clinical trials have documented the potential and safety of CAPA-IVM, which is a form of biphasic IVM, in women with PCOS and/or a high AFC. Procedure setting Oocyte pick-up (OPU) room should be adjacent to the embryology laboratory, directly connected by a pass-through hatch. This design allows aspitated follicular fluid to be transferred immediately and safely to the laboratory Patient selection Women with polycystic ovaries or high antral follicle count have better success rate with biphasic IVM. Resistant ovary syndrome is a definite indication for IVM. Biphasic IVM can be also applied as a method of fertility preservation for young women before cancer treatment. Patient preparation FSH priming before OPU is not necessary. OPU can be arranged at any time if leading follicle(s) in the ovaries are less than 10 mm. No hCG trigger is used before OPU in biphasic IVM. If fresh embryo transfer is preferred, estradiol priming starts at the beginning of the cycle (spontaneous or induced) for endometrium preparation before OPU. The mature oocytes after IVM are used for embryo generation, and cleavage-stage embryos or blastocysts can be transferred in the same treatment cycle. Oocytes pick-up The oocytes retrieval with small follicles is a different technique from conventional OPU in stimulated ovaries. We can used either double lumen needle, 17G external and 19G internal, from Kitazato or single needle with reduced tip, 16.5G body and 19G tip, from Vitrolife (Sense). The vacuum pressure is not different from OPU in stimulated cycles (about 120 mmHg). General anesthesia should be applied. Aspiration medium is supplemented with C-type natriuretic peptide (CNP) and estradiol. Heparin is not used in aspiration medium. Droplets of follicle fluid are aspirated into tubes containing aspiration medium. The collected tubes should be transfer to laboratory as soon as possible. COCs searching and processing Identification of immature compacted cumulus-oocyte-complexes (COC) in bloody follicular aspirates diluted in aspiration medium requires embryologist training. The COCs in this case are smaller and more compacted. An additional filtration step, using a 70-μm pore cell strainer, is applied to harvest very small COCs left in diluted fluid. The obtained COCs are rinsed in pre-IVM media before going through two phases of CAPA-IVM culture. CAPA-IVM method The CAPA-IVM procedure consists of two phases: • The first is a pre-IVM culture phase of 24–26 hours. Intact immature COCs are cultured in IVM media supplemented with CNP, FSH, insulin, and estradiol to maintain meiotic arrest. This phase preserves the mutual communication between oocytes and cumulus cells, enhancing oocyte cytoplasmic maturation. • The second is an IVM culture phase of 30–32 hours. Oocytes are cultured in IVM media, with supplements including amphiregulin, FSH, insulin, and estradiol, to complete oocyte nuclear maturation. Mature oocytes after two phases of culture are then inseminated with sperm to produce zygotes and embryos invitro. The insemination technique and embryo culture procedure are similar to that of conventional IVF/ICSI protocol.
Zitieren
APA
Ho, T. (2026). L26/O-243 How to set up an efficient IVM program. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.241
Vancouver
Ho T. L26/O-243 How to set up an efficient IVM program. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.241
BibTeX
@article{Ho2026,
author = {Ho, T.},
title = {L26/O-243 How to set up an efficient IVM program},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.241}
}
EUVIMED